Inge M. Lankhuizen

567 total citations
14 papers, 465 citations indexed

About

Inge M. Lankhuizen is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Inge M. Lankhuizen has authored 14 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Inge M. Lankhuizen's work include Neuroendocrine regulation and behavior (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Heart Failure Treatment and Management (3 papers). Inge M. Lankhuizen is often cited by papers focused on Neuroendocrine regulation and behavior (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Heart Failure Treatment and Management (3 papers). Inge M. Lankhuizen collaborates with scholars based in Netherlands, China and Switzerland. Inge M. Lankhuizen's co-authors include Dirk J. Duncker, Jos M. J. Lamers, Michiel Dalinghaus, Willem A. Helbing, L.M. Scheek, Arie van Tol, Regien G. Schoemaker, Ilze Bot, Theo J.C. van Berkel and Erik A.L. Biessen and has published in prestigious journals such as Journal of Lipid Research, Cardiovascular Research and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Inge M. Lankhuizen

14 papers receiving 450 citations

Peers

Inge M. Lankhuizen
Inge M. Lankhuizen
Citations per year, relative to Inge M. Lankhuizen Inge M. Lankhuizen (= 1×) peers Michael Browatzki

Countries citing papers authored by Inge M. Lankhuizen

Since Specialization
Citations

This map shows the geographic impact of Inge M. Lankhuizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge M. Lankhuizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge M. Lankhuizen more than expected).

Fields of papers citing papers by Inge M. Lankhuizen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge M. Lankhuizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge M. Lankhuizen. The network helps show where Inge M. Lankhuizen may publish in the future.

Co-authorship network of co-authors of Inge M. Lankhuizen

This figure shows the co-authorship network connecting the top 25 collaborators of Inge M. Lankhuizen. A scholar is included among the top collaborators of Inge M. Lankhuizen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge M. Lankhuizen. Inge M. Lankhuizen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhou, Zhichao, Inge M. Lankhuizen, Heleen M. van Beusekom, et al.. (2018). Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids. Frontiers in Pharmacology. 9. 255–255. 8 indexed citations
2.
Zhou, Zhichao, Inge M. Lankhuizen, Joachim Jankowski, et al.. (2013). Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation. Pharmacological Research. 77. 22–29. 19 indexed citations
3.
Bot, Ilze, Martine Bot, Sandra H. van Heiningen, et al.. (2010). Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice. Cardiovascular Research. 89(1). 244–252. 56 indexed citations
4.
Bot, Ilze, J. Wouter Jukema, Inge M. Lankhuizen, Theo J.C. van Berkel, & Erik A.L. Biessen. (2010). Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. Atherosclerosis. 214(2). 295–300. 42 indexed citations
5.
Dalinghaus, Michiel, Inge M. Lankhuizen, Karel Bezstarosti, et al.. (2007). Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. Journal of Molecular and Cellular Cardiology. 43(2). 197–209. 27 indexed citations
6.
Agnetti, Giulio, Karel Bezstarosti, Inge M. Lankhuizen, et al.. (2006). Recent Developments in Proteomics: Implications for the Study of Cardiac Hypertrophy and Failure. Cell Biochemistry and Biophysics. 44(1). 11–30. 21 indexed citations
7.
Dalinghaus, Michiel, Inge M. Lankhuizen, Paul Steendijk, et al.. (2006). Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. American Journal of Physiology-Heart and Circulatory Physiology. 291(4). H1580–H1586. 102 indexed citations
8.
Dalinghaus, Michiel, Inge M. Lankhuizen, Karel Bezstarosti, et al.. (2005). Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: Correlations with the degree of hypertrophy. PROTEOMICS. 5(10). 2519–2530. 53 indexed citations
9.
Lie, J. T., et al.. (2005). Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1738(1-3). 48–53. 10 indexed citations
10.
Sierksma, Aafje, Susanne H. F. Vermunt, Inge M. Lankhuizen, et al.. (2004). Effect of Moderate Alcohol Consumption on Parameters of Reverse Cholesterol Transport in Postmenopausal Women. Alcoholism Clinical and Experimental Research. 28(4). 662–666. 35 indexed citations
11.
Crom, Rini de, Teus van Gent, Rien van Haperen, et al.. (2002). Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. Journal of Lipid Research. 43(11). 1875–1880. 74 indexed citations
12.
Lankhuizen, Inge M., et al.. (2002). Chronic vasopressin V1A but not V2 receptor antagonism prevents heart failure in chronically infarcted rats. European Journal of Pharmacology. 449(1-2). 135–141. 9 indexed citations
13.
Lankhuizen, Inge M., Richard van Veghel, Pramod R. Saxena, & Regien G. Schoemaker. (2001). Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift. European Journal of Pharmacology. 423(2-3). 195–202. 5 indexed citations
14.
Lankhuizen, Inge M., Richard van Veghel, Pramod R. Saxena, & Regien G. Schoemaker. (2000). [Arg8]-Vasopressin-Induced Responses on Coronary and Mesenteric Arteries of Rats with Myocardial Infarction: The Effects of V1a-and V2-Receptor Antagonists. Journal of Cardiovascular Pharmacology. 36(1). 38–44. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026